Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Therapeutic Perspectives in the Systemic Treatment of Kaposi's Sarcoma.
Cancers (Basel). 2022 Jan 18;14(3):484. doi: 10.3390/cancers14030484.
Cancers (Basel). 2022.
PMID: 35158752
Free PMC article.
Review.
Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIV.
Costagliola D, Potard V, Lang S, de Castro N, Cotte L, Duval X, Duvivier C, Grabar S, Mary-Krause M, Partisani M, Ronot-Bregigeon S, Simon A, Tattevin P, Weiss L, Zucman D, Katlama C, Raffi F, Boccara F.
Costagliola D, et al. Among authors: ronot bregigeon s.
J Infect Dis. 2020 Feb 3;221(4):516-522. doi: 10.1093/infdis/jiz481.
J Infect Dis. 2020.
PMID: 31828320
Item in Clipboard
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
Segal-Maurer S, DeJesus E, Stellbrink HJ, Castagna A, Richmond GJ, Sinclair GI, Siripassorn K, Ruane PJ, Berhe M, Wang H, Margot NA, Dvory-Sobol H, Hyland RH, Brainard DM, Rhee MS, Baeten JM, Molina JM; CAPELLA Study Investigators.
Segal-Maurer S, et al.
N Engl J Med. 2022 May 12;386(19):1793-1803. doi: 10.1056/NEJMoa2115542.
N Engl J Med. 2022.
PMID: 35544387
Clinical Trial.
Item in Clipboard
Lack of correlation between the size of HIV proviral DNA reservoir and the level of immune activation in HIV-infected patients with a sustained undetectable HIV viral load for 10 years.
Poizot-Martin I, Faucher O, Obry-Roguet V, Nicolino-Brunet C, Ronot-Bregigeon S, Dignat-George F, Tamalet C.
Poizot-Martin I, et al. Among authors: ronot bregigeon s.
J Clin Virol. 2013 Aug;57(4):351-5. doi: 10.1016/j.jcv.2013.04.007. Epub 2013 May 8.
J Clin Virol. 2013.
PMID: 23664725
Item in Clipboard
Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial.
Ogbuagu O, Segal-Maurer S, Ratanasuwan W, Avihingsanon A, Brinson C, Workowski K, Antinori A, Yazdanpanah Y, Trottier B, Wang H, Margot N, Dvory-Sobol H, Rhee MS, Baeten JM, Molina JM; GS-US-200-4625 investigators.
Ogbuagu O, et al.
Lancet HIV. 2023 Aug;10(8):e497-e505. doi: 10.1016/S2352-3018(23)00113-3. Epub 2023 Jul 11.
Lancet HIV. 2023.
PMID: 37451297
Clinical Trial.
Item in Clipboard
Cite
Cite